Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
    • Technical Review
    • Clinical Review
      • Round 1
        • Item 0: Background & Action Plan
        • Item 1: CER Update Frequency
        • Item 2: Device Description & Claims
        • Item 3: Clinical Data
        • Item 4: Usability
        • Item 5: PMS Plan
        • Item 6: PMCF Plan
        • Item 7: Risk
        • MDCG 2020-13 & CER Template (reference)
          • MDCG 2020-13 (CEAR) sections
          • CER Template sections
        • Adequacy review
        • Coverage matrix
        • task-3b2-3b3-legacy-rwe-study
        • task-3b4-mrmc-dark-phototypes
  • Pricing
  • Public tenders
  • BSI Non-Conformities
  • Clinical Review
  • Round 1
  • MDCG 2020-13 & CER Template (reference)

MDCG 2020-13 and CER Template — Reference Material

This folder contains faithful markdown transcriptions of two external reference documents that guided the post-BSI Round 1 restructuring of our Clinical Evaluation Report (R-TF-015-003). The documents themselves are third-party material reproduced here solely as internal working reference; authoritative copies are the PDFs committed alongside this page.

Document identity note

The folder is named MDCG-2020-01 because the PDF uploaded here is filenamed MDCG-2020-01.pdf — but the PDF's actual content is MDCG 2020-13 (Clinical Evaluation Assessment Report template, July 2020). That is what has been transcribed under mdcg-assessment/. The folder name is retained to match the filename for provenance, not as a claim about the document identity.

MDCG 2020-1 (Guidance on Clinical Evaluation (MDR) / Performance Evaluation (IVDR) of Medical Device Software) is a different document — it is the source of the three-pillar evidence framework (VCA, Technical Performance, Clinical Performance) that the CEP sets and the CER reports against. The authoritative MDCG 2020-1 PDF lives in the QMS at applicable-standards-and-regulations/04-eu-medical-devices/Guides/04-g07-mdcg-2020-1-clinical-evaluation-mdsw/, and split-part working copies are at round-1/item-0/MDCG-2020-1/. MDCG 2020-1 itself is not transcribed in this folder; if a future BSI round needs section-level quoting of MDCG 2020-1, the same sub-agent conversion pattern used here should be applied to that PDF.

What lives here​

ReferenceSource PDFPurposeMarkdown folder
MDCG 2020-13 — Clinical Evaluation Assessment Report template (July 2020)MDCG-2020-01.pdf (folder name retained from upload; document is MDCG 2020-13)The EU notified-body CEAR template — what BSI uses to score our CER. Sections A–K.mdcg-assessment/
Free CER Template (Mantra Systems, Edition 2)CER Template.pdfA fully-worked MDR-compliant CER structure — what a compliant CER should contain and in what order. 14 numbered sections.cer-template/

Why markdown (and not just the PDF)?​

  1. Searchable and quotable: every assessment criterion and template heading is now addressable by URL/anchor, so the CER, the BSI response docs, and the coverage matrix can link to exact paragraphs.
  2. Diffable: when MDCG or Mantra issue updates, we can diff the markdown to see exactly what changed.
  3. CI-verifiable coverage: the coverage-matrix.mdx at the Round 1 root cross-references every section heading here to a CER anchor; a CI script fails the build if any link rots.

Conversion notes​

  • Automated PDF → markdown pipelines were tried and produced unusable output on landscape-oriented tables (MDCG §C/§D) and the benefit-risk formula (CER §10). Content here was produced by Claude Code sub-agents, one per section, each reading the source PDF pages directly and writing a single output file following a shared conversion contract (GFM pipe tables, escaped fill-in fields, KaTeX math, footnotes preserved).
  • Exact wording has been preserved. Cross-references (e.g. "Section F", "Annex II") were not rewritten to relative links during conversion — the later Phase B refactor links them.
  • Each file starts with # Section … followed by an italic provenance line *Source: <pdf> pages X-Y*.

How this folder relates to BSI Round 1​

The BSI Round 1 findings (items 1–7) identified structural and traceability gaps in the existing CER. Phase A of the remediation is this reference conversion; Phase B restructures the CER in place so every MDCG 2020-13 section, every CER Template section, and every BSI finding maps to a verifiable anchor in R-TF-015-003.

Previous
Response
Next
MDCG 2020-13 (CEAR) sections
  • What lives here
  • Why markdown (and not just the PDF)?
  • Conversion notes
  • How this folder relates to BSI Round 1
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)